Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Buffini & Company Launches Do It N.O.W. Marketing Campaign, Steering Real Estate Agent Success Through 2024's Fluctuating Market
-
OSS Joins Two Key U.S. DoD Consortiums, SCEC and SOSSEC
-
Pentagon to Deliver Report on Domestic Processing of Seafloor Nodules by March 1 as President Biden Signs NDAA
-
Safe & Green Holdings CEO Provides Letter to Shareholders
-
CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Hashdex Bitcoin Futures ETF Successfully Transfers to Tidal's Commodities Trust I
-
Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)
-
Carpenter Technology Announces Conference Call and Webcast
-
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief
-
Bel Fuse Announces Participation in the Needham Growth Conference
-
Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
-
Sofwave Medical Receives 510(k) Marketing Clearance for Pure Impact™ Strength and Muscle Toning Body Module Utilizing PlyoPulse™ EMS Technology
-
Oatly Announces Nationwide Availability at The Coffee Bean & Tea Leaf®
-
Cellectar Biosciences to Announce Top-line Data from WM Pivotal Trial on January 8, 2024
-
Nano Dimension Announces Record Fourth Quarter and Full Year 2023 Preliminary Results
-
Safe & Green Holdings CEO Provides Letter to Shareholders
-
NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National University
-
Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals’ Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Resumes Patient Enrollment
-
NewtekOne, Inc. Announces Record Loan Closings for the Fourth Quarter and Full Year 2023
-
Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024
-
Last Call for Companies to Apply to the World’s Largest Accelerator for Technologies Enabled by Optics, Photonics, and Imaging
-
Haydock Finance Subscribes to Additional Appex Now Products – Dock and Lane
-
RDE, Inc. (Restaurant.com) Completes Acquisition of CardCash.com, Creating $100 Million+ Incentives Business
-
Oatly Announces Nationwide Availability at The Coffee Bean & Tea Leaf®
-
Finacity Facilitates Increase and Expansion of Accounts Receivable Securitization Program to $1.5 Billion with a $1 Billion Accordion Feature for Bunge
-
Workhorse Group Receives HVIP Approval from California Air Resources Board for the W56
-
Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Akero Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Akero Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
DRIVEITAWAY HOLDINGS CEO PROVIDES YEAR-END MESSAGE TO SHAREHOLDERS
-
Anthony J. Annino Joins Obra Capital as Senior Managing Director, Head of Longevity
-
DFCU Financial Continues Tradition of Member Rewards for the 18th Consecutive Year With $40 Million Cash Back Payout
-
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
-
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
-
LeapCharger Corporation Unveils Updated & Ambitious Mission Statement: Global Expansion, Technological Advancements, and Market Diversification
-
LeapCharger Corporation Unveils Updated & Ambitious Mission Statement: Global Expansion, Technological Advancements, and Market Diversification
-
ZyVersa Therapeutics CEO, Stephen C. Glover, Issues Letter to Shareholders Providing Outlook for 2024
-
Selah Freedom Raises Awareness for Human Trafficking Prevention Month With Resources To Eradicate Sex Trafficking in the U.S.
-
Notification of managers and closely related parties’ transactions with A.P. Møller - Mærsk A/S shares in connection with share buy-back program
-
CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Xeriant Completes R&D Fire Testing for NEXBOARD™ in Key Step Towards Pilot Production
-
MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR's TCR-T Cell Pipeline
-
MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR's TCR-T Cell Pipeline
-
Flash News: OKX Wallet Now Integrated with Jones DAO, a Yield, Strategy, and Liquidity Protocol
-
Ardelyx to Provide Company Update on IBSRELA® and Host a KOL Discussion on the IBS-C Landscape on Monday, January 8
-
Delaware Lottery Launches Online Sports Betting With The Transition To BetRivers Powering The State’s New Online Casinos & Online Sportsbooks
-
CAPREIT Announces Timing of Year End 2023 Results & Conference Call
-
Delaware Lottery Launches Online Sports Betting With The Transition To BetRivers Powering The State’s New Online Casinos & Online Sportsbooks
